Zurich Cantonal Bank
TBIO

Zurich Cantonal Bank’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Zurich Cantonal Bank’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,211
Closed -$171K – 2835
2021
Q2 		$171K Hold
6,211
– – ﹤0.01% 1910
2021
Q1 		$102K Buy
6,211
+1,999
+47% +$45.5K ﹤0.01% 2153
2020
Q4 		$78K Hold
4,212
– – ﹤0.01% 2314
2020
Q3 		$57K Buy
+4,212
New +$64.9K ﹤0.01% 2214

Zurich Cantonal Bank's TBIO Position: Q3 2021 in Review

Zurich Cantonal Bank sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 6,211 shares — an estimated $171K sold.

Zurich Cantonal Bank first reported a position in TBIO in Q3 2020 and held it in 4 quarters. The position peaked at $171K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Zurich Cantonal Bank reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Zurich Cantonal Bank sold 6,211 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $171K.
  • Zurich Cantonal Bank first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Zurich Cantonal Bank's Translate Bio, Inc. Common Stock position peaked at $171K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Zurich Cantonal Bank's 13F filing for Q3 2021, filed 15 Nov 2021.